Élodie Constant

588 total citations
9 papers, 230 citations indexed

About

Élodie Constant is a scholar working on Rheumatology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Élodie Constant has authored 9 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 1 paper in Nephrology. Recurrent topics in Élodie Constant's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Élodie Constant is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Élodie Constant collaborates with scholars based in France, United States and Zambia. Élodie Constant's co-authors include Hubert Marotte, Yves‐Marie Pers, Daniel Wendling, Joseph Lambert, Philippe Gaudin, Marie Godfrin-Valnet, Jean-Françis Maillefert, Christian Jørgensen, D. Denarié and Thierry Thomas and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoporosis International and Lara D. Veeken.

In The Last Decade

Élodie Constant

9 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Élodie Constant France	7	197	57	53	49	33	9	230
Marian H. van Beers-Tas Netherlands	9	197 1.0×	23 0.4×	52 1.0×	43 0.9×	33 1.0×	13	247
Melinda Kedves Hungary	5	172 0.9×	31 0.5×	59 1.1×	85 1.7×	36 1.1×	6	238
S. Cohen United States	5	148 0.8×	30 0.5×	87 1.6×	50 1.0×	50 1.5×	8	250
Adrian Levitsky Sweden	7	105 0.5×	15 0.3×	34 0.6×	31 0.6×	16 0.5×	20	166
Peigen He China	6	86 0.4×	17 0.3×	30 0.6×	48 1.0×	17 0.5×	8	147
Regina Cseuz United States	4	146 0.7×	59 1.0×	80 1.5×	43 0.9×	26 0.8×	8	233
Mikhail Volkov Netherlands	7	128 0.6×	22 0.4×	22 0.4×	84 1.7×	17 0.5×	17	239
Claire Blanchard‐Delaunay France	7	78 0.4×	92 1.6×	47 0.9×	46 0.9×	40 1.2×	10	197
Ewa Stanisławska‐Biernat Poland	4	123 0.6×	11 0.2×	31 0.6×	23 0.5×	30 0.9×	9	155
Lin‐Pierre Zhao France	7	35 0.2×	63 1.1×	74 1.4×	28 0.6×	17 0.5×	25	178

Countries citing papers authored by Élodie Constant

Since Specialization

Citations

This map shows the geographic impact of Élodie Constant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élodie Constant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élodie Constant more than expected).

Fields of papers citing papers by Élodie Constant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Élodie Constant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élodie Constant. The network helps show where Élodie Constant may publish in the future.

Co-authorship network of co-authors of Élodie Constant

This figure shows the co-authorship network connecting the top 25 collaborators of Élodie Constant. A scholar is included among the top collaborators of Élodie Constant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Élodie Constant. Élodie Constant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Gandjbakhch, Frédérique, Benjamin Granger, R. Freund, et al.. (2017). Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR). RMD Open. 3(1). e000343–e000343. 7 indexed citations

Pers, Yves‐Marie, Marie Godfrin-Valnet, Joseph Lambert, et al.. (2015). Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient. The Journal of Rheumatology. 42(4). 580–584. 48 indexed citations

Trombert, Béatrice, et al.. (2015). Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service. Osteoporosis International. 26(12). 2869–2875. 6 indexed citations

Pers, Yves‐Marie, Roxane Schaub, Élodie Constant, et al.. (2014). Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis. Joint Bone Spine. 82(1). 25–30. 46 indexed citations

Denarié, D., Élodie Constant, Thierry Thomas, & Hubert Marotte. (2014). Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients?. Mediators of Inflammation. 2014. 1–7. 27 indexed citations

Pers, Yves‐Marie, Marie Godfrin-Valnet, Joseph Lambert, et al.. (2014). AB0453 Response to TOCILIZUMAB in Rheumatoid Arthritis is not Influenced by the Body Mass Index of the Patient. Annals of the Rheumatic Diseases. 73. 958–958. 14 indexed citations

Constant, Élodie, Mélanie Rinaudo-Gaujous, Béatrice Pallot-Pradès, et al.. (2014). THU0164 Tnf-Alpha Bioactivity: A New Biomarker of Aspa Activity in Patients with Tnf-Alpha Blockers. Annals of the Rheumatic Diseases. 73. 237–237. 1 indexed citations

Pers, Yves‐Marie, Élodie Constant, Joseph Lambert, et al.. (2013). Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice. Lara D. Veeken. 53(1). 76–84. 80 indexed citations

Pers, Yves‐Marie, Élodie Constant, Joseph Lambert, et al.. (2012). THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD. Annals of the Rheumatic Diseases. 71. 197–197. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact